The major limitation of this study is lack of FGF15KO/overexpressing mice to elucidate the molecular mechanisms of FGF15/FGFR4 signaling pathway contributing to NASH progression and HCC development. Here, FGFR4 is linked to metabolic dysfunction-associated steatohepatitis.